Measurement of Antioxidant Activity on Postoperative Inflammation in Patients Undergoing Ophthalmic Surgery
NCT05905237 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132
Last updated 2024-12-04
Summary
This trial hypothesized that novel laser refractive surgery techniques (PRK, LASIK, SMILE) or laser-assisted cataract surgery (FLACAS) could suppress postoperative inflammation and improve recovery in patients by reducing oxidative stress generated by the surgical procedure. It is also intended to verify whether the new laser technology is necessary for clinical use in groups with low antioxidant activity through the detection of antioxidant activity in the eyes of patients.
Conditions
- Cataract
- Myopia
Interventions
- PROCEDURE
-
Cataract surgery, Femtosecond-LASIK, SMILE
Cataract surgery includes both conventional and femtosecond laser assisted. Femtosecond-LASIK and SMILE are options for patients to correct myopia.
Sponsors & Collaborators
-
Nobel Eye Institute
collaborator UNKNOWN -
Chang Gung Memorial Hospital
lead OTHER
Principal Investigators
-
Hung-Chi Chen, PhD · Chang Gung Memorial Hospital
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-07-12
- Primary Completion
- 2023-07-28
- Completion
- 2023-07-28
Countries
- Taiwan
Study Locations
More Related Trials
-
Iris Vascular Area Density-Based Preoperative Pain-Risk Screening and Intervention in Second-Eye Cataract Surgery
NCT07291089 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation
NCT01603030 ·Status: UNKNOWN ·Phase: PHASE3
-
Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty
NCT00485108 ·Status: COMPLETED ·Phase: NA
-
Study for Optimizing Anti-inflammatory Prophylaxis
NCT03383328 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)
NCT01193127 ·Status: COMPLETED ·Phase: PHASE2
-
Time Serial Analysis on Preemptive Analgesia of Preoperative Topical Diclofenac and Ketorolac in Photorefractive Keratectomy(PRK)
NCT01761071 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)
NCT00414011 ·Status: COMPLETED ·Phase: NA
-
Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical Trial
NCT03886779 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy
NCT02955641 ·Status: UNKNOWN ·Phase: NA
-
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
NCT01475877 ·Status: COMPLETED
-
Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
NCT01367249 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation
NCT02163824 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK
NCT05973253 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
NCT00469690 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery Patients
NCT02646072 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK
NCT00347204 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care
NCT00698724 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery
NCT00909324 ·Status: COMPLETED ·Phase: PHASE4
-
Protection of Corneal Epithelium Using Chitosan-N-acetylcysteine Eye Drops During and/or After Cataract Surgery
NCT05064189 ·Status: COMPLETED ·Phase: NA
-
Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Post Operative Inflammation in LASIK Surgery
NCT00330824 ·Status: COMPLETED ·Phase: NA
-
Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop
NCT06131476 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery
NCT01048593 ·Status: TERMINATED ·Phase: PHASE2
-
The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements
NCT02030990 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Prednisolone Acetate Eye Drops for Pain Intervention in Second Eye Cataract Surgery
NCT06614348 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
NSAID vs Steroid in Trabeculectomy Wound Management
NCT03751059 ·Status: UNKNOWN ·Phase: PHASE4